Nursing care
Dopamine: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Dopamine's effect depends entirely on the dose infused: low doses favour renal perfusion, middle doses increase heart rate and contractility, and high doses cause vasoconstriction. It is titrated on an infusion pump through a central line, with continuous cardiac and blood pressure monitoring throughout.
Why this drug and not another
Dopamine is chosen when a clinician wants a single agent whose effect can be shifted along a spectrum by adjusting the rate, rather than switching drugs as the clinical picture changes. At low doses it acts on dopaminergic receptors to support renal blood flow; in the middle range it stimulates beta-1 receptors to raise heart rate and contractility; at high doses alpha-1 effects dominate and it vasoconstricts.
That dose-dependent range is the reason it appears in shock states where the target keeps shifting, though norepinephrine has largely replaced it as first-line for septic shock in current guidelines. It remains in use for symptomatic bradycardia unresponsive to atropine and in some cases of cardiogenic shock.
Administration and timing
Dopamine goes through a central line whenever possible, because extravasation from a peripheral site causes tissue necrosis from the vasoconstrictive effect. It is delivered on an infusion pump, never as a bolus, and titrated in small increments against the response you are targeting, whether that is urine output, heart rate, or blood pressure.
Have phentolamine available for extravasation, and know the peripheral site policy at your institution if a central line is not yet in place, since some units permit short-term peripheral use with strict monitoring in an emergency.
Monitoring parameters
Continuous ECG and frequent, ideally arterial-line, blood pressure monitoring are standard for the duration of the infusion. Track urine output hourly, since the renal-dose rationale only holds if perfusion is actually improving, and watch for tachyarrhythmias as the dose climbs into the cardiac range.
Assess peripheral pulses and skin colour and temperature in the extremities regularly, because vasoconstriction at higher doses can compromise circulation to the hands, feet, and gut before it shows up anywhere else.
Adverse effects to report
Report new or worsening tachyarrhythmias, chest pain, or a widening pulse pressure that suggests excessive vasoconstriction. Cool, mottled, or painful extremities at the infusion site or distally warrant an immediate check for extravasation or peripheral ischaemia.
Nausea and vomiting can occur at any dose. A sudden drop in urine output despite an unchanged or increased dose is also worth escalating, since it may mean the desired renal effect has reversed into vasoconstriction of the renal vasculature.
Contraindications and cautions
Dopamine is contraindicated in pheochromocytoma and in uncorrected tachyarrhythmias or ventricular fibrillation, where its cardiac-stimulating effect would worsen the underlying problem. Use it cautiously in patients with occlusive vascular disease, since vasoconstriction at higher doses can precipitate ischaemia in already compromised limbs.
Correct hypovolaemia before starting dopamine wherever possible; giving a vasopressor to a patient who is simply under-filled treats the wrong problem and can mask ongoing fluid loss.
Teaching points the exam tests
The dose-response relationship is the single fact examiners return to: renal at low, cardiac in the middle, vasoconstrictive at high. Expect a question that gives a dose in micrograms per kilogram per minute and asks which effect to anticipate, so know the three bands by name even if you don't memorise exact cutoffs, since ranges vary slightly between references.
The second recurring theme is administration: central line preferred, infusion pump only, never as a bolus, and extravasation is a vasoconstrictor emergency requiring phentolamine. A question describing a peripheral IV site that is blanched and cool after a dopamine infusion is testing whether you recognise extravasation and know the antidote.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our cardiovascular practice questions are the closest set to what this page covers.
Common questions
Why does dopamine need a central line?
At higher doses dopamine causes significant vasoconstriction, and if it leaks into surrounding tissue from a peripheral site it can cause severe local ischaemia and necrosis. A central line delivers the drug directly into a large vessel where dilution is immediate, reducing that risk.
What should a nurse do if dopamine extravasates?
Stop the infusion at that site, leave the cannula in place briefly to aspirate any residual drug, and notify the prescriber immediately. Phentolamine, injected locally around the site, is the standard treatment to counteract the vasoconstriction and limit tissue damage.
How is dopamine dosed differently from norepinephrine?
Dopamine's effect changes with the dose itself, moving through renal, cardiac, and vasoconstrictive ranges as the rate increases. Norepinephrine is a more consistent vasoconstrictor and inotrope across its typical dosing range, which is part of why it has become preferred first-line in septic shock.
What vital sign change should prompt stopping a dopamine infusion?
A new tachyarrhythmia, a significant unexplained rise in blood pressure, or signs of peripheral ischaemia such as cool, mottled extremities should prompt an immediate call to the prescriber and reassessment of the dose. The infusion is not stopped abruptly without direction unless the patient is haemodynamically unstable, since dopamine has a short half-life and effects reverse quickly once titrated down.
More on cardiovascular
Guides on this